BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32880937)

  • 1. Urticarial vasculitis in a COVID-19 recovered patient.
    Nasiri S; Dadkhahfar S; Abasifar H; Mortazavi N; Gheisari M
    Int J Dermatol; 2020 Oct; 59(10):1285-1286. PubMed ID: 32880937
    [No Abstract]   [Full Text] [Related]  

  • 2. Urticaria and urticarial vasculitis.
    Guha B; Youngberg G; Krishnaswamy G
    Compr Ther; 2003; 29(2-3):146-56. PubMed ID: 14606344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urticarial vasculitis secondary to H1N1 vaccination.
    Hughes R; Lacour JP; Baldin B; Reverte M; Ortonne JP; Passeron T
    Acta Derm Venereol; 2010 Nov; 90(6):651-2. PubMed ID: 21057759
    [No Abstract]   [Full Text] [Related]  

  • 4. Urticarial vasculitis.
    Chang S; Carr W
    Allergy Asthma Proc; 2007; 28(1):97-100. PubMed ID: 17390766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urticarial vasculitis].
    Rodionov AN; Domaseva TV
    Vestn Dermatol Venerol; 1989; (4):59-63. PubMed ID: 2763711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.
    Demitsu T; Yoneda K; Kakurai M; Sasaki K; Hiratsuka Y; Azuma R; Yamada T; Umemoto N
    J Dermatol; 2010 Sep; 37(9):827-9. PubMed ID: 20883370
    [No Abstract]   [Full Text] [Related]  

  • 7. Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance.
    Kharkar V; Vishwanath T; Mahajan S; Joshi R; Gole P
    Clin Exp Dermatol; 2021 Dec; 46(8):1596-1597. PubMed ID: 34115904
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
    Batioğlu F; Taner P; Aydintuğ OT; Heper AO; Ozmert E
    Cutan Ocul Toxicol; 2006; 25(4):281-5. PubMed ID: 17162415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination.
    Baraldi C; Boling LB; Patrizi A; Prodi C; Deleonardi G; Gaspari V; Misciali C
    Am J Dermatopathol; 2022 Mar; 44(3):198-200. PubMed ID: 34291744
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.
    Her MY; Song JY; Kim DY
    J Korean Med Sci; 2009 Feb; 24(1):184-6. PubMed ID: 19270838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocomplementemic urticarial vasculitis in mixed connective tissue disease.
    Calistru AM; Lisboa C; Cruz MJ; Delgado L; Poças L; Azevedo F
    Dermatol Online J; 2010 Dec; 16(12):8. PubMed ID: 21199634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement].
    Kervarrec T; Binois R; Bléchet C; Estève É
    Ann Dermatol Venereol; 2015 Oct; 142(10):557-62. PubMed ID: 25613197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urticarial vasculitis.
    Cardoso PA; de Oliveira ZP; Alves VA; Candelori I; Croce J; Rivitti EA
    Allergol Immunopathol (Madr); 1990; 18(4):191-5. PubMed ID: 2264552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic response of urticarial vasculitis to indomethacin.
    Millns JL; Randle HW; Solley GO; Dicken CH
    J Am Acad Dermatol; 1980 Oct; 3(4):349-55. PubMed ID: 7430455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urticarial vasculitis and urticarial autoinflammatory syndromes.
    Marzano AV; Tavecchio S; Venturini M; Sala R; Calzavara-Pinton P; Gattorno M
    G Ital Dermatol Venereol; 2015 Feb; 150(1):41-50. PubMed ID: 25586657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticaria (angioedema) and COVID-19 infection.
    Najafzadeh M; Shahzad F; Ghaderi N; Ansari K; Jacob B; Wright A
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e568-e570. PubMed ID: 32525251
    [No Abstract]   [Full Text] [Related]  

  • 17. [McDuffie hypocomplementemic urticarial vasculitis. Two cases and review of the literature].
    el Maghraoui A; Abouzahir A; Mahassine F; Tabache F; Bezza A; Ghafir D; Ohayon V; Archane MI
    Rev Med Interne; 2001 Jan; 22(1):70-4. PubMed ID: 11218302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine-induced urticarial vasculitis.
    Dash S; Behera B; Sethy M; Mishra J; Garg S
    Dermatol Ther; 2021 Sep; 34(5):e15093. PubMed ID: 34369046
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis.
    Davis MD; Daoud MS; Kirby B; Gibson LE; Rogers RS
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):899-905. PubMed ID: 9631995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypocomplementemic vasculitis treated with dapsone].
    Hérault M; Mazet J; Beurey P; Cuny JF; Barbaud A; Schmutz JL; Bursztejn AC
    Ann Dermatol Venereol; 2010; 137(8-9):541-5. PubMed ID: 20804899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.